Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362458144> ?p ?o ?g. }
- W4362458144 abstract "Abstract The effectiveness of neoadjuvant immune checkpoint inhibitor (ICI) therapy is confirmed in clinical trials; however, the patients suitable for receiving this therapy remain unspecified. Previous studies have demonstrated that the tumor microenvironment (TME) dominates immunotherapy; therefore, an effective TME classification strategy is required. In this study, five crucial immunophenotype‐related molecules (WARS, UBE2L6, GZMB, BATF2, and LAG‐3) in the TME are determined in five public gastric cancer (GC) datasets ( n = 1426) and an in‐house sequencing dataset ( n = 79). Based on this, a GC immunophenotypic score (IPS) is constructed using the least absolute shrinkage and selection operator (LASSO) Cox, and randomSurvivalForest. IPS Low is characterized as immune‐activated, and IPS High is immune‐silenced. Data from seven centers ( n = 1144) indicate that the IPS is a robust and independent biomarker for GC and superior to the AJCC stage. Furthermore, patients with an IPS Low and a combined positive score of ≥5 are likely to benefit from neoadjuvant anti‐PD‐1 therapy. In summary, the IPS can be a useful quantitative tool for immunophenotyping to improve clinical outcomes and provide a practical reference for implementing neoadjuvant ICI therapy for patients with GC." @default.
- W4362458144 created "2023-04-05" @default.
- W4362458144 creator A5001432963 @default.
- W4362458144 creator A5002281586 @default.
- W4362458144 creator A5019806453 @default.
- W4362458144 creator A5019887424 @default.
- W4362458144 creator A5031251029 @default.
- W4362458144 creator A5035633007 @default.
- W4362458144 creator A5035701638 @default.
- W4362458144 creator A5043039345 @default.
- W4362458144 creator A5044082173 @default.
- W4362458144 creator A5057347003 @default.
- W4362458144 creator A5058103854 @default.
- W4362458144 creator A5060735508 @default.
- W4362458144 creator A5063131315 @default.
- W4362458144 creator A5071174475 @default.
- W4362458144 creator A5072823040 @default.
- W4362458144 creator A5073070877 @default.
- W4362458144 creator A5073199916 @default.
- W4362458144 creator A5077153850 @default.
- W4362458144 creator A5078507731 @default.
- W4362458144 date "2023-03-30" @default.
- W4362458144 modified "2023-10-17" @default.
- W4362458144 title "Tumor Immunophenotyping‐Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer" @default.
- W4362458144 cites W1980137951 @default.
- W4362458144 cites W1985987855 @default.
- W4362458144 cites W2019607817 @default.
- W4362458144 cites W2021329831 @default.
- W4362458144 cites W2039123767 @default.
- W4362458144 cites W2070555748 @default.
- W4362458144 cites W2079936875 @default.
- W4362458144 cites W2115462905 @default.
- W4362458144 cites W2124427232 @default.
- W4362458144 cites W2136731993 @default.
- W4362458144 cites W2146512944 @default.
- W4362458144 cites W2162222767 @default.
- W4362458144 cites W2167973264 @default.
- W4362458144 cites W2294356527 @default.
- W4362458144 cites W2338576144 @default.
- W4362458144 cites W2560367415 @default.
- W4362458144 cites W2578528809 @default.
- W4362458144 cites W2655262992 @default.
- W4362458144 cites W2756181170 @default.
- W4362458144 cites W2763933536 @default.
- W4362458144 cites W2769419513 @default.
- W4362458144 cites W2793364080 @default.
- W4362458144 cites W2796207838 @default.
- W4362458144 cites W2897815318 @default.
- W4362458144 cites W2907564726 @default.
- W4362458144 cites W2920863623 @default.
- W4362458144 cites W2924122631 @default.
- W4362458144 cites W2939093246 @default.
- W4362458144 cites W3003310139 @default.
- W4362458144 cites W3009140068 @default.
- W4362458144 cites W3047106569 @default.
- W4362458144 cites W3080722828 @default.
- W4362458144 cites W3132811153 @default.
- W4362458144 cites W3166392727 @default.
- W4362458144 cites W3168239748 @default.
- W4362458144 cites W3168540735 @default.
- W4362458144 cites W3195744482 @default.
- W4362458144 cites W3201363819 @default.
- W4362458144 cites W3201914217 @default.
- W4362458144 cites W4200339743 @default.
- W4362458144 cites W4205506118 @default.
- W4362458144 cites W4206384216 @default.
- W4362458144 cites W4206719482 @default.
- W4362458144 cites W4210511445 @default.
- W4362458144 cites W4220909053 @default.
- W4362458144 cites W4225394054 @default.
- W4362458144 cites W4280599663 @default.
- W4362458144 cites W4281490788 @default.
- W4362458144 cites W4281697720 @default.
- W4362458144 cites W4281732693 @default.
- W4362458144 cites W4282946303 @default.
- W4362458144 cites W4291802844 @default.
- W4362458144 cites W4310759330 @default.
- W4362458144 cites W4362458144 @default.
- W4362458144 doi "https://doi.org/10.1002/advs.202207417" @default.
- W4362458144 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36998102" @default.
- W4362458144 hasPublicationYear "2023" @default.
- W4362458144 type Work @default.
- W4362458144 citedByCount "1" @default.
- W4362458144 countsByYear W43624581442023 @default.
- W4362458144 crossrefType "journal-article" @default.
- W4362458144 hasAuthorship W4362458144A5001432963 @default.
- W4362458144 hasAuthorship W4362458144A5002281586 @default.
- W4362458144 hasAuthorship W4362458144A5019806453 @default.
- W4362458144 hasAuthorship W4362458144A5019887424 @default.
- W4362458144 hasAuthorship W4362458144A5031251029 @default.
- W4362458144 hasAuthorship W4362458144A5035633007 @default.
- W4362458144 hasAuthorship W4362458144A5035701638 @default.
- W4362458144 hasAuthorship W4362458144A5043039345 @default.
- W4362458144 hasAuthorship W4362458144A5044082173 @default.
- W4362458144 hasAuthorship W4362458144A5057347003 @default.
- W4362458144 hasAuthorship W4362458144A5058103854 @default.
- W4362458144 hasAuthorship W4362458144A5060735508 @default.
- W4362458144 hasAuthorship W4362458144A5063131315 @default.
- W4362458144 hasAuthorship W4362458144A5071174475 @default.
- W4362458144 hasAuthorship W4362458144A5072823040 @default.